GlassScriptPhysician profile
Marcus W Balters
NPI 1205940186
$27,409.67
in general payments reported to CMS, 2019-2025
8 companies · $26.95 in 2025
The $26.95 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $75.16 · 2021: $67.91 · 2022: $1,335 · 2023: $25K · 2025: $26.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $24K · Travel and Lodging: $1,750 · Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $23,500.00 |
| Travel and Lodging | $1,749.64 |
| Food and Beverage | $105.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $27,153.14 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $84.48 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $36.88 | 2019 | |
| W. L. Gore & Associates, INC. | $32.66 | 2020 | |
| Atricure, INC. | $26.95 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Getinge USA Sales, LLC | $26.41 | 2019 | |
| Davol INC. | $26.00 | 2020 | |
| Abbott Laboratories | $23.15 | 2023 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Balters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.